STRYKER CORP Product Liability Accrual, Period Expense
STRYKER CORP (SYK) reported Product Liability Accrual, Period Expense of $18.00 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProductLiabilityAccrualPeriodExpense · last filed 2024-02-14
- STRYKER CORP product liability accrual, period expense for the quarter ending 2023-12-31 was $6.00M.
- STRYKER CORP product liability accrual, period expense for the quarter ending 2023-09-30 was $9.00M.
- STRYKER CORP product liability accrual, period expense for the quarter ending 2023-06-30 was $3.00M, a 25.00% decline year-over-year.
- STRYKER CORP product liability accrual, period expense for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- STRYKER CORP product liability accrual, period expense for fiscal 2023 was $18.00M.
- STRYKER CORP product liability accrual, period expense for fiscal 2022 was -$15.00M, a 114.56% decline from fiscal 2021.
- STRYKER CORP product liability accrual, period expense for fiscal 2021 was $103.00M, a 505.88% increase from fiscal 2020.
- STRYKER CORP product liability accrual, period expense for fiscal 2020 was $17.00M, a 91.15% decline from fiscal 2019.
| Period end | Product Liability Accrual, Period Expense 3 month | Product Liability Accrual, Period Expense 6 month | Product Liability Accrual, Period Expense 9 month | Product Liability Accrual, Period Expense 12 month |
|---|---|---|---|---|
| 2023-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $15.00M derived: sum of 2 quarters · filed 2024-02-14 | $18.00M derived: sum of 3 quarters · filed 2024-02-14 | $18.00M 10-K · filed 2024-02-14 |
| 2023-09-30 | $9.00M 10-Q · filed 2023-11-03 | $12.00M derived: sum of 2 quarters · filed 2023-11-03 | $12.00M 10-Q · filed 2023-11-03 | -$17.00M derived: sum of 4 quarters · filed 2024-02-14 |
| 2023-06-30 | $3.00M 10-Q · filed 2023-08-04 | $3.00M 10-Q · filed 2023-08-04 | -$26.00M derived: sum of 3 quarters · filed 2024-02-14 | -$30.00M derived: sum of 4 quarters · filed 2024-02-14 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-02 | -$29.00M derived: sum of 2 quarters · filed 2024-02-14 | -$33.00M derived: sum of 3 quarters · filed 2024-02-14 | -$29.00M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-12-31 | -$29.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | -$33.00M derived: sum of 2 quarters · filed 2024-02-14 | -$29.00M derived: sum of 3 quarters · filed 2024-02-14 | -$15.00M 10-K · filed 2024-02-14 |
| 2022-09-30 | -$4.00M 10-Q · filed 2023-11-03 | $0.00 derived: sum of 2 quarters · filed 2023-11-03 | $14.00M 10-Q · filed 2023-11-03 | $19.00M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | $4.00M 10-Q · filed 2023-08-04 | $18.00M 10-Q · filed 2023-08-04 | $23.00M derived: sum of 3 quarters · filed 2024-02-14 | $39.00M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $14.00M 10-Q · filed 2023-05-02 | $19.00M derived: sum of 2 quarters · filed 2024-02-14 | $35.00M derived: sum of 3 quarters · filed 2024-02-14 | $111.00M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $21.00M derived: sum of 2 quarters · filed 2024-02-14 | $97.00M derived: sum of 3 quarters · filed 2024-02-14 | $103.00M 10-K · filed 2024-02-14 |
| 2021-09-30 | $16.00M 10-Q · filed 2022-11-01 | $92.00M derived: sum of 2 quarters · filed 2022-11-01 | $98.00M 10-Q · filed 2022-11-01 | $119.00M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-06-30 | $76.00M 10-Q · filed 2022-07-27 | $82.00M 10-Q · filed 2022-07-27 | $103.00M derived: sum of 3 quarters · filed 2023-02-10 | $105.00M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-03-31 | $6.00M 10-Q · filed 2022-04-29 | $27.00M derived: sum of 2 quarters · filed 2023-02-10 | $29.00M derived: sum of 3 quarters · filed 2023-02-10 | $29.00M derived: sum of 4 quarters · filed 2023-02-10 |
| 2020-12-31 | $21.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $23.00M derived: sum of 2 quarters · filed 2023-02-10 | $23.00M derived: sum of 3 quarters · filed 2023-02-10 | $17.00M 10-K · filed 2023-02-10 |
| 2020-09-30 | $2.00M 10-Q · filed 2021-10-29 | $2.00M derived: sum of 2 quarters · filed 2021-10-29 | -$4.00M 10-Q · filed 2021-10-29 | $9.00M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-06-30 | $0.00 10-Q · filed 2021-07-28 | -$6.00M 10-Q · filed 2021-07-28 | $7.00M derived: sum of 3 quarters · filed 2022-02-11 | $56.00M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-03-31 | -$6.00M 10-Q · filed 2021-04-28 | $7.00M derived: sum of 2 quarters · filed 2022-02-11 | $56.00M derived: sum of 3 quarters · filed 2022-02-11 | $173.00M derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | $13.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $62.00M derived: sum of 2 quarters · filed 2022-02-11 | $179.00M derived: sum of 3 quarters · filed 2022-02-11 | $192.00M 10-K · filed 2022-02-11 |
| 2019-09-30 | $49.00M 10-Q · filed 2020-10-30 | $166.00M derived: sum of 2 quarters · filed 2020-10-30 | $179.00M 10-Q · filed 2020-10-30 | $192.00M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-06-30 | $117.00M 10-Q · filed 2020-07-31 | $130.00M 10-Q · filed 2020-07-31 | $143.00M derived: sum of 3 quarters · filed 2021-02-11 | $147.00M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-03-31 | $13.00M 10-Q · filed 2020-05-01 | $26.00M derived: sum of 2 quarters · filed 2021-02-11 | $30.00M derived: sum of 3 quarters · filed 2021-02-11 | $32.00M derived: sum of 4 quarters · filed 2021-02-11 |
| 2018-12-31 | $13.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $17.00M derived: sum of 2 quarters · filed 2021-02-11 | $19.00M derived: sum of 3 quarters · filed 2021-02-11 | $23.00M 10-K · filed 2021-02-11 |
| 2018-09-30 | $4.00M 10-Q · filed 2019-10-30 | $6.00M derived: sum of 2 quarters · filed 2019-10-30 | $10.00M 10-Q · filed 2019-10-30 | $19.00M derived: sum of 4 quarters · filed 2020-02-06 |
| 2018-06-30 | $2.00M 10-Q · filed 2019-07-26 | $6.00M 10-Q · filed 2019-07-26 | $15.00M derived: sum of 3 quarters · filed 2020-02-06 | $81.00M derived: sum of 4 quarters · filed 2020-02-06 |
| 2018-03-31 | $4.00M 10-Q · filed 2019-04-24 | $13.00M derived: sum of 2 quarters · filed 2020-02-06 | $79.00M derived: sum of 3 quarters · filed 2020-02-06 | |
| 2017-12-31 | $9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | $75.00M derived: sum of 2 quarters · filed 2020-02-06 | $173.00M 10-K · filed 2020-02-06 | |
| 2017-09-30 | $66.00M 10-Q · filed 2018-10-26 | $164.00M 10-Q · filed 2018-10-26 | ||
| 2016-12-31 | $158.00M 10-K · filed 2019-02-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |